Silvia Ministrini

Silvia Ministrini

Auto-generated profile, based on publicly available information

Silvia Ministrini

University of Brescia at ASST Spedali Civili di Brescia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2018 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
SMSilvia Ministrini
Silvia Ministrini
LSLeonardo Solaini
Leonardo Solaini
CCChiara Cipollari
Chiara Cipollari
SSSilvia Sofia
Silvia Sofia
EMelisabetta marino
elisabetta marino
GTGuido A. M. Tiberio
Guido A. M. Tiberio

9 January 2020 in Cancers
Verified
Journal Article
Open access
PDF file
SMSilvia Ministrini
Silvia Ministrini
MBMaria Bencivenga
Maria Bencivenga
Leonardo SolainiLeonardo Solaini
Leonardo Solaini
CCChiara Cipollari
Chiara Cipollari
SSSilvia Sofia
Silvia Sofia
Guido Alberto Massimo TiberioGuido Alberto Massimo Tiberio
Guido Alberto Massimo Tiberio
Background/Aim: This work explored the prognostic role of curative versus non-curative surgery, the prognostic value of the various localizations of metastatic disease, and the possibility of identifying patients to be submitted to aggressive therapies. Patients and Methods: Retrospective chart review of stage IV patients operated on in our institutions. Results: Two hundred and eighty-two patients were considered; 73.4% had a single metastatic presentation. In 117 cases, a curative (R0) resection of primary and metastases was possible; 75 received a R1 resection and 90 a palliative R2 gastrectomy. Surgery was integrated with chemotherapy in multiple forms: conversion therapy, HIPEC, neo-adjuvant and adjuvant treatment. Median overall survival (OS) of the entire cohort was 10.9 months, with 14 months for the R0 subgroup. There was no correlation between metastasis site and survival. At multivariate analysis, several variables associated with the lymphatic sphere showed prognostic value, as well as tumor histology and the curativity of the surgical procedure, with a worse prognosis associated with a low number of resected nodes, D1 lymphectomy, pN3, non-intestinal histology, and R+ surgery. Considering the subgroup of R0 patients, the variables pT, pN and D displayed an independent prognostic role with a cumulative effect, showing that patients with no more than 1 risk factor can reach a median survival of 33 months. Conclusions: Our data show that the possibility of effective care also exists for Western patients with stage IV gastric cancer.

8 January 2019 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SMS. Ministrini
S. Ministrini
GBG. Baronio
G. Baronio
FZF. Zorzi
F. Zorzi
LBL. Bercich
L. Bercich
LGL. Grazioli
L. Grazioli
NPN. Portolani
N. Portolani
Although gout is a common disease, the presence of gouty tophi outside joints is rare and in literature, there is to date only one report of hepatic tophaceous nodule. We would like to highlight here the difficult diagnostic workup in a patient with history of cancer and the presence of a tophus inside the liver. Moreover, we address the possible etiologic role of chronic inflammation related to tophi and liver cancer. We present the case of a 72-year-old man with a localization of gouty tophus in the liver, who thereafter developed a hepatocellular carcinoma (HCC) in the same site. The patient was followed up after surgery for left renal cancer from 1992 to 2011, when a hepatic nodule was discovered for the first time. After a detailed evaluation, the nodule was classified as a urate tophus of the liver. However, further follow-up showed that the nodule increased in size and changed its characteristics, bringing to the diagnosis of HCC. With the present case report, we would discuss the possible neoplastic degeneration of a gouty tophus and its etiologic role favouring cellular degeneration linked to chronic inflammation. We would also highlight the importance of histopathological evaluation of hepatic lesions in gouty patients at high risk of liver neoplasm, due to the difficulty in characterizing gouty tophi by imaging.

4 November 2015 in World Journal of Emergency Surgery
Verified
Journal Article
Open access
PDF file
SMSilvia Ministrini
Silvia Ministrini
GBGian Luca Baiocchi
Gian Luca Baiocchi
FPFrida Pittiani
Frida Pittiani
DLDaniele Lomiento
Daniele Lomiento
FGFederico Gheza
Federico Gheza
NPNazario Portolani
Nazario Portolani
The presence at CT scan of more retained bullets than expected could be a very difficult interpretation challenge in the early management of gunshot wounds. The modern non operative management of haemodinamically stable patients without peritonitis requires that the trajectory of the bullet is clearly recognized. This clinical case reporting of a gunshot wound without evident entry hole, allows to discuss the diagnostic and therapeutic implications in the management of gunshot wounds cases with atypical entry and/or exit holes.

26 March 2018 in Updates in Surgery
Verified
Journal Article
Closed access
DZDaniela Zanotti
Daniela Zanotti
GBGian Luca Baiocchi
Gian Luca Baiocchi
ACArianna Coniglio
Arianna Coniglio
BMBorzoueh Mohammadi
Borzoueh Mohammadi
SMSilvia Ministrini
Silvia Ministrini
KDKhaled Dawas
Khaled Dawas

29 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
Maria BencivengaMaria Bencivenga
Maria Bencivenga
SMSilvia Ministrini
Silvia Ministrini
PMPaolo Morgagni
Paolo Morgagni
GMGianni Mura
Gianni Mura
Daniele MarrelliDaniele Marrelli
Daniele Marrelli
Guido Alberto Massimo TiberioGuido Alberto Massimo Tiberio
Guido Alberto Massimo Tiberio
Background: Interest in the field of metastatic gastric cancer has grown in recent years, and the identification of oligometastatic patients plays a critical role as it consents to their inclusion in multimodal treatment strategies, which include systemic therapy but also surgery with curative intent. To collect sound clinical data on this subject, The Italian Research Group on Gastric Cancer developed a prospective multicentric observational register of metastatic gastric cancer patients called META-GASTRO. Methods: Data on 383 patients in Meta-Gastro were mined to help our understanding of oligometastatic, according to its double definition: quantitative/anatomical and dynamic. Results: the quantitative/anatomical definition applies to single-site metastases independently from the metastatic site (p < 0.001) to peritoneal metastases with PCI ≤ 12 (p = 0.009), to 1 or 2 hepatic metastases (p = 0.024) and nodal metastases in station 16 (p = 0.002). The dynamic definition applies to a percentage of cases variable according to the metastatic site: 8%, 13.5 and 23.8% for hepatic, lymphatic and peritoneal sites, respectively. In all cases, the OS of patients benefitting from conversion therapy was similar to those of cases deemed operable at diagnosis and operated after neoadjuvant chemotherapy. Conclusions: META-GASTRO supports the two-fold definition of oligometastatic gastric cancer: the quantitative/anatomical one, which accounts for 30% of our population, and the dynamic one, observed in 16% of our cases.